MIM
SGFY

MetLife Investment Management’s Signify Health, Inc. SGFY Stock Holding History

MetLife Investment Management’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,849
Closed -$53K – 2837
2022
Q4 		$53K Buy
1,849
+228
+14% +$6.58K ﹤0.01% 2751
2022
Q3 		$47.3K Sell
1,621
-32
-2% -$737 ﹤0.01% 2763
2022
Q2 		$22.8K Buy
1,653
+374
+29% +$5.26K ﹤0.01% 2837
2022
Q1 		$23.2K Buy
+1,279
New +$18.3K ﹤0.01% 2706

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

MetLife Investment Management's SGFY Position: Q1 2023 in Review

MetLife Investment Management sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 1,849 shares — an estimated $53K sold.

MetLife Investment Management first reported a position in SGFY in Q1 2022 and held it in 4 quarters. The position peaked at $53K in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • MetLife Investment Management reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • MetLife Investment Management sold 1,849 Signify Health, Inc. shares in Q1 2023, an estimated $53K.
  • MetLife Investment Management first reported a position in Signify Health, Inc. in Q1 2022 and held it in 4 quarters.
  • MetLife Investment Management's Signify Health, Inc. position peaked at $53K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.